Cilazapril

西拉普利

Report date: 2022/08/10 15:58:02
NME

Base Information

Drug NameCilazapril
Drug Alias Name西那普利Cilazaprilum(1S,9S)-9-[(S)-1-乙氧羰基-3-苯丙基]氨基]-10-氧代八氢哒嗪并[1,2-a][1,2]二氮卓-1-羧酸DynormJustor +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsHypertensionHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1990/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co Ltd
Inactive CompaniesShanghai Roche Pharmaceuticals Ltd
Active IndicationsHypertensionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC09AA08
Related LinksWikipediaDrugBankKEGG